Related Experiment Video
Updated: Dec 17, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
3.2K
Preventing SARS-CoV-2 infection by blocking a tissue serine protease
Katherine C Jankousky1, Jonathan Schultz2, Samuel Windham2
1Department of Medicine, University of Colorado, Anschutz Medical Center Aurora, CO, USA.
Therapeutic Advances in Infectious Disease
|June 25, 2020
Summary
Current treatments for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) are limited. This study explores targeting the viral spike protein
Area of Science:
- Virology
- Infectious Diseases
- Pharmacology
Background:
- The COVID-19 pandemic, caused by SARS-CoV-2, lacks proven pharmacologic treatments.
- Traditional antiviral strategies focus on blocking viral replication steps.
- An alternative approach is needed to combat SARS-CoV-2.
Purpose of the Study:
- To investigate a novel therapeutic strategy for COVID-19.
- To explore the potential of inhibiting SARS-CoV-2 entry into host cells.
- To identify new pharmacological targets for SARS-CoV-2 infection.
Main Methods:
- Focuses on the molecular mechanisms of viral entry.
- Investigates the role of the viral surface spike protein.
- Proposes targeting the cleavage of the spike protein.
Main Results:
- The cleavage of the SARS-CoV-2 spike protein is crucial for viral entry.
- Inhibiting spike protein cleavage could prevent infection.
- This presents a potential new avenue for antiviral drug development.
Conclusions:
- Targeting the cleavage of the SARS-CoV-2 spike protein offers a promising therapeutic strategy.
- This approach could prevent viral entry into epithelial cells.
- Further research is warranted to develop effective inhibitors.
